                               SEQUENCE LISTING	

<110> WYETH 
 
<120> METHODS FOR PURIFICATION OF SINGLE DOMAIN ANTIGEN BINDING
      MOLECULES

<130> W2023-7038WO

<140>
<141>

<150> 61/109,481
<151> 2008-10-29

<160> 12    

<170> PatentIn version 3.5

<210> 1
<211> 382
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"


<220>
<221> signal
<222> (1)..(19)

<220>
<221> mat_peptide
<222> (20)..(382)

<400> 1
Met Gly Trp Ser Cys Ile Ile Leu Phe Leu Val Ala Thr Ala Thr Gly 
                -15                 -10                 -5      


Val His Ser Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln 
        -1  1               5                   10              


Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe 
    15                  20                  25                  


Ser Asp Tyr Trp Met Tyr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu 
30                  35                  40                  45  


Glu Trp Val Ser Glu Ile Asn Thr Asn Gly Leu Ile Thr Lys Tyr Pro 
                50                  55                  60      


Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn 
            65                  70                  75          


Thr Leu Tyr Leu Gln Met Asn Ser Leu Arg Pro Glu Asp Thr Ala Val 
        80                  85                  90              


Tyr Tyr Cys Ala Arg Ser Pro Ser Gly Phe Asn Arg Gly Gln Gly Thr 
    95                  100                 105                 


Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Ser Glu 
110                 115                 120                 125 


Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Asn Ser 
                130                 135                 140     


Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Phe Gly 
            145                 150                 155         


Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
        160                 165                 170             


Ser Ile Ser Gly Ser Gly Ser Asp Thr Leu Tyr Ala Asp Ser Val Lys 
    175                 180                 185                 


Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Thr Thr Leu Tyr Leu 
190                 195                 200                 205 


Gln Met Asn Ser Leu Arg Pro Glu Asp Thr Ala Val Tyr Tyr Cys Thr 
                210                 215                 220     


Ile Gly Gly Ser Leu Ser Arg Ser Ser Gln Gly Thr Leu Val Thr Val 
            225                 230                 235         


Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Ser Glu Val Gln Leu Val 
        240                 245                 250             


Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly Ser Leu Arg Leu Ser 
    255                 260                 265                 


Cys Ala Ala Ser Gly Phe Thr Phe Ser Asp Tyr Trp Met Tyr Trp Val 
270                 275                 280                 285 


Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser Glu Ile Asn Thr 
                290                 295                 300     


Asn Gly Leu Ile Thr Lys Tyr Pro Asp Ser Val Lys Gly Arg Phe Thr 
            305                 310                 315         


Ile Ser Arg Asp Asn Ala Lys Asn Thr Leu Tyr Leu Gln Met Asn Ser 
        320                 325                 330             


Leu Arg Pro Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg Ser Pro Ser 
    335                 340                 345                 


Gly Phe Asn Arg Gly Gln Gly Thr Leu Val Thr Val Ser Ser
350                 355                 360 


<210> 2
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 2
Asp Tyr Trp Met Tyr 
1               5   


<210> 3
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 3
Glu Ile Asn Thr Asn Gly Leu Ile Thr Lys Tyr Pro Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 4
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 4
Ser Pro Ser Gly Phe Asn 
1               5       


<210> 5
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 5
Ser Phe Gly Met Ser 
1               5   


<210> 6
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 6
Ser Ile Ser Gly Ser Gly Ser Asp Thr Leu Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 7
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 7
Gly Gly Ser Leu Ser Arg 
1               5       


<210> 8
<211> 35
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"


<220>
<221> VARIANT
<222> (6)..(10)
<223> /replace=" "

<220>
<221> misc_feature
<222> (6)..(10)
<223> /note="Residues given in the sequence have no preference 
      with respect to those in the annotations for said positions"

<220>
<221> VARIANT
<222> (11)..(15)
<223> /replace=" "

<220>
<221> misc_feature
<222> (11)..(15)
<223> /note="Residues given in the sequence have no preference 
      with respect to those in the annotations for said positions"

<220>
<221> VARIANT
<222> (16)..(20)
<223> /replace=" "

<220>
<221> misc_feature
<222> (16)..(20)
<223> /note="Residues given in the sequence have no preference 
      with respect to those in the annotations for said positions"

<220>
<221> VARIANT
<222> (21)..(25)
<223> /replace=" "

<220>
<221> misc_feature
<222> (21)..(25)
<223> /note="Residues given in the sequence have no preference 
      with respect to those in the annotations for said positions"

<220>
<221> VARIANT
<222> (26)..(30)
<223> /replace=" "

<220>
<221> misc_feature
<222> (26)..(30)
<223> /note="Residues given in the sequence have no preference 
      with respect to those in the annotations for said positions"

<220>
<221> VARIANT
<222> (31)..(35)
<223> /replace=" "

<220>
<221> misc_feature
<222> (31)..(35)
<223> /note="Residues given in the sequence have no preference 
      with respect to those in the annotations for said positions"

<400> 8
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly 
1               5                   10                  15

Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly 
            20                  25                  30                  

Gly Gly Ser
        35


<210> 9
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 9
Gly Gly Gly Gly Ser Gly Gly Gly Ser 
1               5                   


<210> 10
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"


<220>
<221> VARIANT
<222> (21)..(25)
<223> /replace=" "

<220>
<221> misc_feature
<222> (21)..(25)
<223> /note="Residues given in the sequence have no preference 
      with respect to those in the annotations for said positions"

<220>
<221> VARIANT
<222> (26)..(30)
<223> /replace=" "

<220>
<221> misc_feature
<222> (26)..(30)
<223> /note="Residues given in the sequence have no preference 
      with respect to those in the annotations for said positions"

<400> 10
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly 
1               5                   10                  15      


Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser 
            20                  25                  30


<210> 11
<211> 441
<212> PRT
<213> Staphylococcal sp.

<400> 11
Ala Gln His Asp Glu Ala Gln Gln Asn Ala Phe Tyr Gln Val Leu Asn 
1               5                   10                  15      


Met Pro Asn Leu Asn Ala Asp Gln Arg Asn Gly Phe Ile Gln Ser Leu 
            20                  25                  30          


Lys Asp Asp Pro Ser Gln Ser Ala Asn Val Leu Gly Glu Ala Gln Lys 
        35                  40                  45              


Leu Asn Asp Ser Gln Ala Pro Lys Ala Asp Ala Gln Gln Asn Lys Phe 
    50                  55                  60                  


Asn Lys Asp Gln Gln Ser Ala Phe Tyr Glu Ile Leu Asn Met Pro Asn 
65                  70                  75                  80  


Leu Asn Glu Glu Gln Arg Asn Gly Phe Ile Gln Ser Leu Lys Asp Asp 
                85                  90                  95      


Pro Ser Gln Ser Thr Asn Val Leu Gly Glu Ala Lys Lys Leu Asn Glu 
            100                 105                 110         


Ser Gln Ala Pro Lys Ala Asp Asn Asn Phe Asn Lys Glu Gln Gln Asn 
        115                 120                 125             


Ala Phe Tyr Glu Ile Leu Asn Met Pro Asn Leu Asn Glu Glu Gln Arg 
    130                 135                 140                 


Asn Gly Phe Ile Gln Ser Leu Lys Asp Asp Pro Ser Gln Ser Ala Asn 
145                 150                 155                 160 


Leu Leu Ala Glu Ala Lys Lys Leu Asn Glu Ser Gln Ala Pro Lys Ala 
                165                 170                 175     


Asp Asn Lys Phe Asn Lys Glu Gln Gln Asn Ala Phe Tyr Glu Ile Leu 
            180                 185                 190         


His Leu Pro Asn Leu Asn Glu Glu Gln Arg Asn Gly Phe Ile Gln Ser 
        195                 200                 205             


Leu Lys Asp Asp Pro Ser Gln Ser Ala Asn Leu Leu Ala Glu Ala Lys 
    210                 215                 220                 


Lys Leu Asn Asp Ala Gln Ala Pro Lys Ala Asp Asn Lys Phe Asn Lys 
225                 230                 235                 240 


Glu Gln Gln Asn Ala Phe Tyr Glu Ile Leu His Leu Pro Asn Leu Thr 
                245                 250                 255     


Glu Glu Gln Arg Asn Gly Phe Ile Gln Ser Leu Lys Asp Asp Pro Ser 
            260                 265                 270         


Val Ser Lys Glu Ile Leu Ala Glu Ala Lys Lys Leu Asn Asp Ala Gln 
        275                 280                 285             


Ala Pro Lys Glu Glu Asp Asn Asn Lys Pro Gly Lys Glu Asp Gly Asn 
    290                 295                 300                 


Lys Pro Gly Lys Glu Asp Gly Asn Lys Pro Gly Lys Glu Asp Asn Lys 
305                 310                 315                 320 


Lys Pro Gly Lys Glu Asp Gly Asn Lys Pro Gly Lys Glu Asp Asn Lys 
                325                 330                 335     


Lys Pro Gly Lys Glu Asp Gly Asn Lys Pro Gly Lys Glu Asp Gly Asn 
            340                 345                 350         


Lys Pro Gly Lys Glu Asp Gly Asn Lys Pro Gly Lys Glu Asp Gly Asn 
        355                 360                 365             


Lys Pro Gly Lys Glu Asp Gly Asn Gly Val His Val Val Lys Pro Gly 
    370                 375                 380                 


Asp Thr Val Asn Asp Ile Ala Lys Ala Asn Gly Thr Thr Ala Asp Lys 
385                 390                 395                 400 


Ile Ala Ala Asp Asn Lys Leu Ala Asp Lys Asn Met Ile Lys Pro Gly 
                405                 410                 415     


Gln Glu Leu Val Val Asp Lys Lys Gln Pro Ala Asn His Ala Asp Ala 
            420                 425                 430         


Asn Lys Ala Gln Ala Leu Pro Glu Thr 
        435                 440     


<210> 12
<211> 58
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 12
Val Asp Asn Lys Phe Asn Lys Glu Gln Gln Asn Ala Phe Tyr Glu Ile 
1               5                   10                  15      


Leu His Leu Pro Asn Leu Asn Glu Glu Gln Arg Asn Ala Phe Ile Gln 
            20                  25                  30          


Ser Leu Lys Asp Asp Pro Ser Gln Ser Ala Asn Leu Leu Ala Glu Ala 
        35                  40                  45              


Lys Lys Leu Asn Asp Ala Gln Ala Pro Lys 
    50                  55              


